Abstract
Micro-RNAs (miRNA) are short non-coding sequences involved in the biological regulatory process. The miRNAs show a unique expression in diseases, resulting in pathogenesis. Identifying the novel compounds is interesting during this process. The miRNA is a biomarker that helps to detect cancer at an early stage through pathogenesis. Azobenzene and pyrazole are novel compounds, having a cytotoxic effect on cancer cells. These novel compounds are molecular probes used in breast cancer therapy. The viral-based systems have few limitations, such as toxicity and immunogenicity. Therefore, the non-viral based lipoplex and polyplex systems are attractive due to no size limitations for the transfection of micro RNAs. The conventional drug delivery systems have a large size and low drug efficacy at the target site. The nanoparticles prepared by nanoprecipitation methods are attractive in cancer therapy. Thus, the miRNA acts as a powerful tool and identifies the drug target in cancer therapy.
Keywords: micro RNA, drug target, bio-marker, drug discovery, drug delivery, small molecules, cancer therapy.
Current Drug Discovery Technologies
Title:Micro-RNA (miRNA): A Biomarker to Identify Novel Compounds in Drug Discovery and Delivery for Cancer Therapy
Volume: 18 Issue: 6
Author(s): Gokul Paramasivam*
Affiliation:
- Saveetha school of engineering, Department of biomedical engineering, Saveetha Institute of Medical & Technical Sciences (SIMATS), Saveetha Nagar, Thandalam, Chennai - 602 105, TamilNadu,India
Keywords: micro RNA, drug target, bio-marker, drug discovery, drug delivery, small molecules, cancer therapy.
Abstract: Micro-RNAs (miRNA) are short non-coding sequences involved in the biological regulatory process. The miRNAs show a unique expression in diseases, resulting in pathogenesis. Identifying the novel compounds is interesting during this process. The miRNA is a biomarker that helps to detect cancer at an early stage through pathogenesis. Azobenzene and pyrazole are novel compounds, having a cytotoxic effect on cancer cells. These novel compounds are molecular probes used in breast cancer therapy. The viral-based systems have few limitations, such as toxicity and immunogenicity. Therefore, the non-viral based lipoplex and polyplex systems are attractive due to no size limitations for the transfection of micro RNAs. The conventional drug delivery systems have a large size and low drug efficacy at the target site. The nanoparticles prepared by nanoprecipitation methods are attractive in cancer therapy. Thus, the miRNA acts as a powerful tool and identifies the drug target in cancer therapy.
Export Options
About this article
Cite this article as:
Paramasivam Gokul *, Micro-RNA (miRNA): A Biomarker to Identify Novel Compounds in Drug Discovery and Delivery for Cancer Therapy, Current Drug Discovery Technologies 2021; 18 (6) : e130921188092 . https://dx.doi.org/10.2174/1570163817999201117114237
DOI https://dx.doi.org/10.2174/1570163817999201117114237 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dendrimers in Therapy for Breast and Colorectal Cancer
Current Medicinal Chemistry Genetic Enhancement in Sport: Just Another Form of Doping?
Recent Patents on DNA & Gene Sequences Subject Index to Volume 4
Current Topics in Medicinal Chemistry Advancement of Targeted Ultrasound Contrast Agents and their Applications in Molecular Imaging and Targeted Therapy
Current Pharmaceutical Design Wnt/β-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options
Current Cancer Drug Targets Colorectal Cancer Microenvironment: Among Nutrition, Gut Microbiota, Inflammation and Epigenetics
Current Pharmaceutical Design Optimized Turmeric Extracts have Potent Anti-Amyloidogenic Effects
Current Alzheimer Research Current Metabolomic Methodologies & their Application to Thermal Stress
Current Metabolomics The Endothelin Axis as Therapeutic Target in Human Malignancies: Present and Future
Current Pharmaceutical Design Liposomal Nanotechnology for Cancer Theranostics
Current Medicinal Chemistry The Neurokinins: Peptidomimetic Ligand Design and Therapeutic Applications
Current Medicinal Chemistry Therapeutic Use of Vitamin D and its Analogues in Autoimmunity
Recent Patents on Inflammation & Allergy Drug Discovery Design and First Results of an Innovative and Dedicated Breast PET
Current Medical Imaging The Evidence for Automated Grading in Diabetic Retinopathy Screening
Current Diabetes Reviews Population Based Helicobacter pylori Screening and Eradication: Advances Versus Side Effects
Current Pharmaceutical Design Chemistry and Pharmacological Properties of Some Natural and Synthetic Antioxidants for Heavy Metal Toxicity
Current Medicinal Chemistry circEPSTI1 Acts as a ceRNA to Regulate the Progression of Osteosarcoma
Current Cancer Drug Targets Combined Modality Treatment of Limited Stage Small Cell Carcinoma of the Lung
Reviews on Recent Clinical Trials Review of Procedures Used for the Extraction of Anti-Cancer Compounds from Tropical Plants
Anti-Cancer Agents in Medicinal Chemistry Berberine: A Fluorescent Alkaloid with a Variety of Applications from Medicine to Chemistry
Mini-Reviews in Organic Chemistry